AstraZeneca's Initial Application for Lupus Injection Turned Down by FDA

Core Viewpoint - The company is collaborating with the U.S. regulator to advance an updated application, with a decision anticipated in the first half of 2026 [1] Group 1 - The company is working with the U.S. regulator to move forward with an updated application [1] - A decision regarding the application is expected in the first half of 2026 [1]